m6A dot blot assays confirmed that siRNA‐mediated knockdown of METTL14 significantly reduced RNA m6A levels in NPC cells, whereas METTL14 overexpression elevated cellular RNA m6A levels (Figure 2A). This evidence concerns the gene METTL14 and nasopharyngeal carcinoma.